Sino Biological,Inc. (SHE:301047)
China flag China · Delayed Price · Currency is CNY
91.92
-7.28 (-7.34%)
Nov 16, 2026, 4:00 PM EST

Sino Biological,Inc. Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
202.27322.3233.351,3162,3802,872
Trading Asset Securities
2,7602,9003,7163,5333,4223,638
Cash & Short-Term Investments
2,9633,2223,9494,8495,8026,511
Cash Growth
-9.17%-18.41%-18.55%-16.43%-10.88%476.77%
Accounts Receivable
208.21180.22151.44126.33141.08154.07
Other Receivables
7.1919.820.1822.0715.666.18
Receivables
215.41200.02171.63148.4156.74160.25
Inventory
70.8179.2264.452.5347.4924.75
Prepaid Expenses
---6.63-6.35
Other Current Assets
31.8816.4322.0612.6517.7216.74
Total Current Assets
3,2813,5184,2085,0696,0246,719
Property, Plant & Equipment
893.99893.1893.55900.9210.96107.57
Long-Term Investments
461.64401.13229.17215.94180.24-
Goodwill
260.98281.93278.38---
Other Intangible Assets
33.840.244.790.81.110.92
Long-Term Deferred Tax Assets
119.85108.05113.81104.6380.2838.26
Long-Term Deferred Charges
44.2850.5459.6959.73499.31
Other Long-Term Assets
300.8250.01227.74249.6434.6415.34
Total Assets
5,3965,5436,0556,6016,5806,890

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
23.8323.7218.2119.3329.234.25
Accrued Expenses
48.3656.6646.0454.344.0936.02
Current Portion of Leases
10.1522.4222.4723.3719.8120.45
Current Income Taxes Payable
24.095.0610.33.056.7611.94
Current Unearned Revenue
31.6130.7735.2322.7420.7113.81
Other Current Liabilities
12.914.165.2613.584.611.89
Total Current Liabilities
150.95152.73197.52136.38125.298.37
Long-Term Leases
30.9931.144.961.6950.6526.9
Long-Term Unearned Revenue
15.8410.072.544.225.63-
Long-Term Deferred Tax Liabilities
32.0234.1136.8431.4129.6412.65
Total Liabilities
229.81228281.8233.7211.11137.92

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
121.64121.64121.64129.2129.268
Additional Paid-In Capital
4,3554,3544,3534,7964,7934,853
Retained Earnings
713.7839.791,3001,4341,4321,809
Comprehensive Income & Other
-24.04-0.65-1.487.9714.5122.11
Shareholders' Equity
5,1665,3155,7736,3676,3696,752
Total Liabilities & Equity
5,3965,5436,0556,6016,5806,890

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
41.1453.5267.3785.0670.4647.36
Net Cash (Debt)
2,9213,1693,8824,7645,7326,463
Net Cash Growth
-8.98%-18.38%-18.51%-16.89%-11.32%472.58%
Net Cash Per Share
24.0226.0530.3436.8750.3260.03
Filing Date Shares Outstanding
121.64121.64121.64129.2129.2129.2
Total Common Shares Outstanding
121.64121.64121.64129.2129.2129.2
Working Capital
3,1303,3654,0104,9335,8996,620
Book Value Per Share
42.4743.6947.4649.2849.3052.26
Tangible Book Value
4,8714,9935,4506,3666,3686,751
Tangible Book Value Per Share
40.0541.0544.8049.2749.2952.26
Buildings
-613.21637.92637.92--
Machinery
-315.79300.85268.29200.86105.49
Construction In Progress
-119.3244.498.55--